SCHEMBL26523765

SCHEMBL26523765

Cc1ccc(C(C)(C)C)cc1C(C)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KIF11 P52732 3/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 2/20 0.36
PDE2A O00408 1/20 0.36
ACHE P22303 1/20 0.35
LMNA P02545 2/20 0.35
TYR P14679 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL799856 0.87 KIF11 (0.44) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL22900080 0.87 TSHR (0.41) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL30786333 0.84 TSHR (0.46) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL1927914 0.84 TSHR (0.46) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL23759275 0.83 TSHR (0.38) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL23759247 0.83 POLB (0.39) TSHRALDH1A1KIF11HPGDALOX15
Ammonia Solution, Strong SCHEMBL486696 0.82 TSHR (0.44) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL23483450 0.80 KIF11 (0.43) TSHRALDH1A1KIF11HPGDALOX15
SCHEMBL8415470 0.78 PDE2A (0.47) TSHRKIF11MEN1MAPTKMT2A
SCHEMBL22799581 0.78 ALDH1A1 (0.40) TSHRALDH1A1KIF11HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11786528-B2 Pyrazolopyrimidine compounds as adenosine receptor antagonists EXSCIENTIA LTD. (GB) 2023-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786528-B2 Pyrazolopyrimidine compounds as adenosine receptor antagonists ADORA1, ADORA3, ADORA2A TSHR 258/4885ALDH1A1 849/4885KIF11 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.